Matthew Ierullo
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Feasibility and Safety of Ex Vivo Delivery of Rituximab to Lung Allografts in Transplant Recipients at High Risk for Epstein-Barr Virus-associated Posttransplant Lymphoproliferative Disorder.
Journal: Transplantation direct
Published: January 17, 2025
Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Journal: Transplantation and cellular therapy
Published: June 05, 2023
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients.
Journal: The Lancet. Infectious diseases
Published: May 15, 2023
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimab.
Journal: The Lancet. Infectious diseases
Published: February 18, 2023
Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 05, 2023
Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.
Journal: Open forum infectious diseases
Published: December 16, 2022
Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: August 31, 2022
Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients.
Journal: Transplantation and cellular therapy
Published: June 06, 2022
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: January 28, 2022
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
Journal: Annals of internal medicine
Published: November 22, 2021
Last Updated: 09/26/2026